Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
- Status
- COMPLETED
- Phase
- PHASE3
Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Carboplatin in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
- Status
- COMPLETED
- Phase
- PHASE2
The p53 Breast Cancer Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
- Status
- UNKNOWN
- Phase
- PHASE1
MEtronomic TrEatment Option in Advanced bReast cAncer
- Status
- COMPLETED
- Phase
- PHASE2